[go: up one dir, main page]

ES2006165A6 - Procedimiento para la preparacion de derivados de 1,4-dihidropiridina y sus sales de adicion farmaceuticamente aceptables - Google Patents

Procedimiento para la preparacion de derivados de 1,4-dihidropiridina y sus sales de adicion farmaceuticamente aceptables

Info

Publication number
ES2006165A6
ES2006165A6 ES8701723A ES8701723A ES2006165A6 ES 2006165 A6 ES2006165 A6 ES 2006165A6 ES 8701723 A ES8701723 A ES 8701723A ES 8701723 A ES8701723 A ES 8701723A ES 2006165 A6 ES2006165 A6 ES 2006165A6
Authority
ES
Spain
Prior art keywords
processes
preparation
pharmaceutical compositions
compositions containing
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8701723A
Other languages
English (en)
Inventor
Hiroaki Satoh
Hiroyasu Koyama
Yoshikuni Suzuki
Toshiji Sugai
Koichi Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Seifun Group Inc
Original Assignee
Nisshin Seifun Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Seifun Group Inc filed Critical Nisshin Seifun Group Inc
Publication of ES2006165A6 publication Critical patent/ES2006165A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

EL INVENTO SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE 1,4-DIHIDROPIRIDINA Y SUS SALES DE ADICION FARMACEUTICAMENTE ACEPTABLES DE LA FORMULAEN QUE R1 ES UN GRUPO DE NITRO O TRIFLUOROMETILO; R2 ES UN GRUPO C1-C6 ALQUILO; R3 ES UN GRUPO PIRIDILO O N-OXIDO DE PIRIDILO, QUE PUEDE ESTAR SUSTITUIDO CON HALOGENO, HIDROXILO, HALO ALQUILO, C1-C6 ALCOXI O C1-C6 ALQUILO, ADEMAS PUEDE ESTAR FUSIONADO CON UN ANILLO DE BENCENO O NAFTALENO ESTANDO SUSTITUIDO DICHO OPCIONALMENTE CON C1-C6 ALQUILO, C1-C6 ALCOXI, HALOGENO O HALO-ALQUILO, SIENDO LOS COMPUESTOS DE LA FORMULA (I) DE ACTIVIDADES VASO-DILATADORAS Y QUE HACEN DESCENDER LA PRESION SANGUINEA, SIENDO ASI UTILES PARA EL TRATAMIENTO DE ENFERMEDADES CARDIACAS ENFERMEDADES CEREBRO-VASCULARES Y DE HIPERTENSION.
ES8701723A 1986-06-13 1987-06-11 Procedimiento para la preparacion de derivados de 1,4-dihidropiridina y sus sales de adicion farmaceuticamente aceptables Expired ES2006165A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61136152A JPH0676405B2 (ja) 1986-06-13 1986-06-13 １，４―ジヒドロピリジン誘導体およびそれを含有する医薬組成物

Publications (1)

Publication Number Publication Date
ES2006165A6 true ES2006165A6 (es) 1989-04-16

Family

ID=15168527

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8701723A Expired ES2006165A6 (es) 1986-06-13 1987-06-11 Procedimiento para la preparacion de derivados de 1,4-dihidropiridina y sus sales de adicion farmaceuticamente aceptables

Country Status (6)

Country Link
US (1) US4877797A (es)
EP (1) EP0249174B1 (es)
JP (1) JPH0676405B2 (es)
CA (1) CA1334591C (es)
DE (1) DE3787319T2 (es)
ES (1) ES2006165A6 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2736269B2 (ja) * 1989-07-20 1998-04-02 日清製粉株式会社 １，４−ジヒドロピリジン医薬組成物
IL117560A0 (en) * 1995-03-30 1996-07-23 Res Dev Foundation Anti-stroke effects of calcium antagonists
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862161A (en) * 1970-01-24 1975-01-21 Bayer Ag 4-pyridyl substituted 1,4-dihydropyridines
DE2218644C3 (de) * 1972-04-18 1982-08-19 Bayer Ag, 5090 Leverkusen Basische Ester von 1,4-Dihydropyridinen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
US4497808A (en) * 1981-12-30 1985-02-05 Ciba-Geigy Corporation N-Oxide compounds useful in the treatment of cardiovascular ailments
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
EP0145956A1 (de) * 1983-11-16 1985-06-26 Ciba-Geigy Ag Neue Amid-Verbindungen
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
US4757071A (en) * 1984-12-14 1988-07-12 Nisshin Flour Milling Co., Ltd. 1,4-dihydropyridine derivatives, and pharmaceutical compositions containing same, useful for treating cardiovascular diseases
JPH0631223B2 (ja) * 1984-12-14 1994-04-27 日清製粉株式会社 １，４−ジヒドロピリジン誘導体およびその製造法

Also Published As

Publication number Publication date
CA1334591C (en) 1995-02-28
JPH0676405B2 (ja) 1994-09-28
EP0249174A1 (en) 1987-12-16
DE3787319T2 (de) 1994-01-05
JPS62292781A (ja) 1987-12-19
US4877797A (en) 1989-10-31
DE3787319D1 (de) 1993-10-14
EP0249174B1 (en) 1993-09-08

Similar Documents

Publication Publication Date Title
MA21502A1 (fr) 4--phenyl-(-piperazinyl)phenols et procedes pour leur preparation .
HUT50316A (en) Process for production of 1-phenyl-3-naphthyl-oxy-propanamines and pharmaceutical preparations containing them
ATE126216T1 (de) Pyrazolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
ATE50256T1 (de) Hypoglycemische thiazolidinedione.
HU900064D0 (en) Process for preparation of new 2-amino pyrimidinone-derivatives
ATE79376T1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DK9185A (da) Dihydropyridazinonderivater og fremgangsmaade til fremstilling deraf
NO882334L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NZ210100A (en) 5h,11h-pyrrolo(2,1-c)(1,4)benzoxazepine derivatives and pharmaceutical compositons
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
HUT53886A (en) Fungicide preparations containing propencarboxylic acid derivatives as agents and process for producing the agents
EP0270093A3 (en) Lactam derivatives, processes for the preparation thereof, pharmaceutical compositions comprising the same, and the use of such derivatives for the manufacture of a medicament having valuable therapeutic properties
ES2006165A6 (es) Procedimiento para la preparacion de derivados de 1,4-dihidropiridina y sus sales de adicion farmaceuticamente aceptables
DK535284A (da) Phenylalkansyrederivater og fremgangsmaade til fremstilling deraf
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
DE68926810D1 (de) Benzoxazepinon-Verfahren
CA2140781A1 (en) Pharmocologically active .alpha.-¬tertiary-aminomethyl|- benzenemethanol derivatives
DK0410343T3 (da) Anvendelse af bisphenolderivater til behandling af diabetes mellitus
ES8504713A1 (es) Un procedimiento para preparar nuevas dihidropiridinas
IL79280A (en) 4-(6-oxo-dihydro or tetrahydropyridazin-3-yl)benzene derivatives,their preparation and pharmaceutical compositions containing them
IL81107A (en) 5(2(furan or thiophen)-1,3-dioxane,4-(2-hydroxyphenyl))-hexenoic acid derivatives,their preparation and pharmaceutical compositions containing them
ATE67197T1 (de) Thiadiazinon-derivate.
MY103236A (en) Novel 2-thienyloxyacetic acid derivatives, a process for their preparation and pharmaceutical preparations containing them
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
GB1471546A (en) 1-acyl-4-substituted alkyl-piperazine or homopiperazine derivatives nad process for preparation thereof

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040601